Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rationale and experience with short daily hemofiltration.

Bertrand L Jaber1, Deborah L Zimmerman

  • 1Division of Nephrology, Tufts-New England Medical Center, Boston, MA, USA.

Seminars in Dialysis
|March 27, 2004
PubMed
Summary

End-stage renal disease (ESRD) patients face high mortality. Increasing hemodialysis time or frequency, or using hemofiltration, may improve outcomes by enhancing solute removal and patient well-being.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Co-prescription of metformin and glucagon-like peptide-1 receptor agonists and metformin-associated lactic acidosis: A case series.

Clinical nephrology. Case studies·2026
Same author

Risk of intracranial hemorrhage in anti-neutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids: a systematic review of case reports.

Rheumatology international·2025
Same author

Bile cast nephropathy: A systematic review of case reports and case series.

World journal of hepatology·2025
Same author

Minimal change disease in treatment-naïve hepatitis C virus infection: A case report and literature review.

Clinical nephrology. Case studies·2025
Same author

Antibiotic treatment of ceftriaxone-susceptible Serratia marcescens bacteremia: A multicenter, retrospective cohort study.

International journal of clinical pharmacology and therapeutics·2025
Same author

Parameters Predictive of Propofol-Associated Acute Pancreatitis in Critically Ill Patients with COVID-19 Pneumonia: A Retrospective Cohort Study.

Journal of intensive care medicine·2024

Area of Science:

  • Nephrology
  • Renal Replacement Therapy

Background:

  • Patients with end-stage renal disease (ESRD) exhibit significantly higher morbidity and mortality rates compared to the general population.
  • The conventional thrice-weekly hemodialysis schedule is nonphysiologic and may contribute to suboptimal patient outcomes.

Purpose of the Study:

  • To explore alternative renal replacement therapies beyond conventional hemodialysis for ESRD patients.
  • To investigate the potential benefits of increasing hemodialysis time/frequency and utilizing hemofiltration.

Main Methods:

  • Review of existing literature on hemodialysis and hemofiltration for ESRD.
  • Exploration of solutions including increased hemodialysis duration/frequency and hemofiltration techniques.
  • Consideration of technological advancements impacting hemofiltration efficacy and accessibility.

Related Experiment Videos

Main Results:

  • Increased hemodialysis time/frequency shows improvements in anemia management, blood pressure control, and quality of life.
  • Hemofiltration, utilizing convective clearance, enhances removal of larger solutes compared to hemodialysis.
  • Preliminary data suggests daily hemofiltration may improve blood pressure, beta2-microglobulin levels, and quality of life.

Conclusions:

  • Conventional hemodialysis presents limitations for ESRD patients.
  • Hemofiltration offers advantages in solute clearance, with technological advancements addressing previous limitations.
  • Daily hemofiltration emerges as a promising treatment option for improving ESRD patient outcomes.